| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.27B | 10.31B | 10.12B | 9.97B | 10.35B | 10.11B |
| Gross Profit | 4.64B | 4.61B | 4.68B | 4.84B | 5.06B | 4.84B |
| EBITDA | 1.16B | 1.18B | 1.34B | 1.70B | 2.06B | 1.89B |
| Net Income | 213.11M | 229.98M | 346.68M | 575.59M | 809.00M | 666.86M |
Balance Sheet | ||||||
| Total Assets | 12.31B | 12.42B | 12.42B | 12.28B | 12.18B | 11.84B |
| Cash, Cash Equivalents and Short-Term Investments | 4.25B | 4.45B | 4.13B | 4.26B | 4.32B | 3.64B |
| Total Debt | 3.35B | 3.35B | 3.39B | 3.35B | 3.48B | 3.73B |
| Total Liabilities | 5.30B | 5.20B | 5.29B | 5.23B | 5.57B | 5.91B |
| Stockholders Equity | 7.01B | 7.23B | 7.13B | 7.05B | 6.61B | 5.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.06B | 841.65M | 699.97M | 1.39B | 1.30B |
| Operating Cash Flow | 0.00 | 1.18B | 849.59M | 710.68M | 1.42B | 1.35B |
| Investing Cash Flow | 0.00 | -132.34M | 6.90M | -86.26M | -35.76M | -96.42M |
| Financing Cash Flow | 0.00 | -723.14M | -991.10M | -685.55M | -701.76M | -856.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥3.27B | 5.25 | ― | 5.23% | -1.35% | -17.35% | |
76 Outperform | ¥271.97B | 14.78 | ― | 2.42% | 9.55% | 9.52% | |
73 Outperform | ¥2.72T | 19.24 | 8.35% | 1.77% | 5.39% | 4.89% | |
73 Outperform | ¥158.65B | 14.99 | ― | 1.39% | 11.23% | 16.49% | |
66 Neutral | ¥10.26B | 24.07 | ― | ― | 5.80% | -43.56% | |
64 Neutral | ¥636.23B | 16.50 | ― | 2.14% | 7.73% | 30.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |